CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Amal Therapeutics

For profit

Also known as: Amal Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 13, 2023

Acquired by Boehringer Ingelheim on Jul 15, 2019

Timeline

2010s

Jun 1, 2012
Amal Therapeutics— Founded
Jul 15, 2019
Boehringer Ingelheim— Acquired By

Drugs by trial phase (5 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (2)

NCT05846516Lead sponsorPhase 1Mar 13, 2023
NCT04046445Lead sponsorPhase 1/Phase 2Jul 22, 2019

Details

Founded: Geneva, CH Jun 1, 2012
Last known activity: Mar 13, 2023